KR102567305B1 - Cosmetic composition for pore shrinking and sebum control containing natural ingredients - Google Patents
Cosmetic composition for pore shrinking and sebum control containing natural ingredients Download PDFInfo
- Publication number
- KR102567305B1 KR102567305B1 KR1020230041851A KR20230041851A KR102567305B1 KR 102567305 B1 KR102567305 B1 KR 102567305B1 KR 1020230041851 A KR1020230041851 A KR 1020230041851A KR 20230041851 A KR20230041851 A KR 20230041851A KR 102567305 B1 KR102567305 B1 KR 102567305B1
- Authority
- KR
- South Korea
- Prior art keywords
- green
- cosmetic composition
- extract
- temperature
- coffee bean
- Prior art date
Links
- 210000002374 sebum Anatomy 0.000 title claims abstract description 33
- 239000000203 mixture Substances 0.000 title claims abstract description 32
- 239000002537 cosmetic Substances 0.000 title claims abstract description 30
- 239000011148 porous material Substances 0.000 title claims abstract description 29
- 239000004615 ingredient Substances 0.000 title description 3
- 239000000284 extract Substances 0.000 claims abstract description 75
- 241000581835 Monodora junodii Species 0.000 claims abstract description 34
- 241000533293 Sesbania emerus Species 0.000 claims abstract description 34
- 241000146226 Physalis ixocarpa Species 0.000 claims abstract description 33
- 235000013399 edible fruits Nutrition 0.000 claims abstract description 25
- 244000063616 Sabal blackburniana Species 0.000 claims abstract description 19
- 230000028327 secretion Effects 0.000 claims abstract description 19
- 239000004480 active ingredient Substances 0.000 claims abstract description 12
- 239000002131 composite material Substances 0.000 claims description 29
- 238000002156 mixing Methods 0.000 claims description 13
- 230000002401 inhibitory effect Effects 0.000 claims description 8
- 238000000034 method Methods 0.000 claims description 3
- 230000003064 anti-oxidating effect Effects 0.000 claims 1
- 230000000694 effects Effects 0.000 abstract description 21
- 230000003078 antioxidant effect Effects 0.000 abstract description 12
- 239000003963 antioxidant agent Substances 0.000 abstract description 8
- 230000000052 comparative effect Effects 0.000 description 30
- 230000005764 inhibitory process Effects 0.000 description 12
- 238000012360 testing method Methods 0.000 description 12
- 238000004519 manufacturing process Methods 0.000 description 10
- 239000000523 sample Substances 0.000 description 10
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 9
- 238000006243 chemical reaction Methods 0.000 description 9
- 238000002360 preparation method Methods 0.000 description 9
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 108010066551 Cholestenone 5 alpha-Reductase Proteins 0.000 description 8
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 8
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 8
- 210000004027 cell Anatomy 0.000 description 8
- 230000001595 contractor effect Effects 0.000 description 8
- 235000006708 antioxidants Nutrition 0.000 description 7
- 239000006210 lotion Substances 0.000 description 7
- 239000002953 phosphate buffered saline Substances 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 239000008213 purified water Substances 0.000 description 7
- 102000001554 Hemoglobins Human genes 0.000 description 6
- 108010054147 Hemoglobins Proteins 0.000 description 6
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 6
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 6
- 230000008602 contraction Effects 0.000 description 6
- 230000002292 Radical scavenging effect Effects 0.000 description 5
- 230000004663 cell proliferation Effects 0.000 description 5
- 229940088597 hormone Drugs 0.000 description 5
- 239000005556 hormone Substances 0.000 description 5
- 239000000243 solution Substances 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- RYYVLZVUVIJVGH-UHFFFAOYSA-N caffeine Chemical compound CN1C(=O)N(C)C(=O)C2=C1N=CN2C RYYVLZVUVIJVGH-UHFFFAOYSA-N 0.000 description 4
- 239000006071 cream Substances 0.000 description 4
- MGJZITXUQXWAKY-UHFFFAOYSA-N diphenyl-(2,4,6-trinitrophenyl)iminoazanium Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1N=[N+](C=1C=CC=CC=1)C1=CC=CC=C1 MGJZITXUQXWAKY-UHFFFAOYSA-N 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 239000002609 medium Substances 0.000 description 4
- 230000007935 neutral effect Effects 0.000 description 4
- 239000013641 positive control Substances 0.000 description 4
- 238000001556 precipitation Methods 0.000 description 4
- NVKAWKQGWWIWPM-ABEVXSGRSA-N 17-β-hydroxy-5-α-Androstan-3-one Chemical compound C1C(=O)CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CC[C@H]21 NVKAWKQGWWIWPM-ABEVXSGRSA-N 0.000 description 3
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 3
- WEVYAHXRMPXWCK-UHFFFAOYSA-N Acetonitrile Chemical compound CC#N WEVYAHXRMPXWCK-UHFFFAOYSA-N 0.000 description 3
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 3
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 3
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 229960003473 androstanolone Drugs 0.000 description 3
- 230000010261 cell growth Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000002474 experimental method Methods 0.000 description 3
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 3
- 150000008442 polyphenolic compounds Chemical class 0.000 description 3
- 235000013824 polyphenols Nutrition 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000006228 supernatant Substances 0.000 description 3
- 239000000725 suspension Substances 0.000 description 3
- 229960003604 testosterone Drugs 0.000 description 3
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 2
- 208000002874 Acne Vulgaris Diseases 0.000 description 2
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 2
- 201000004624 Dermatitis Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 2
- LPHGQDQBBGAPDZ-UHFFFAOYSA-N Isocaffeine Natural products CN1C(=O)N(C)C(=O)C2=C1N(C)C=N2 LPHGQDQBBGAPDZ-UHFFFAOYSA-N 0.000 description 2
- 241000220225 Malus Species 0.000 description 2
- LRHPLDYGYMQRHN-UHFFFAOYSA-N N-Butanol Chemical compound CCCCO LRHPLDYGYMQRHN-UHFFFAOYSA-N 0.000 description 2
- NPGIHFRTRXVWOY-UHFFFAOYSA-N Oil red O Chemical compound Cc1ccc(C)c(c1)N=Nc1cc(C)c(cc1C)N=Nc1c(O)ccc2ccccc12 NPGIHFRTRXVWOY-UHFFFAOYSA-N 0.000 description 2
- XYNPYHXGMWJBLV-VXPJTDKGSA-N Tomatidine Chemical compound O([C@@H]1[C@@H]([C@]2(CC[C@@H]3[C@@]4(C)CC[C@H](O)C[C@@H]4CC[C@H]3[C@@H]2C1)C)[C@@H]1C)[C@@]11CC[C@H](C)CN1 XYNPYHXGMWJBLV-VXPJTDKGSA-N 0.000 description 2
- 239000002253 acid Substances 0.000 description 2
- 206010000496 acne Diseases 0.000 description 2
- POJWUDADGALRAB-UHFFFAOYSA-N allantoin Chemical compound NC(=O)NC1NC(=O)NC1=O POJWUDADGALRAB-UHFFFAOYSA-N 0.000 description 2
- -1 and melanoidin Chemical compound 0.000 description 2
- YZXBAPSDXZZRGB-DOFZRALJSA-N arachidonic acid Chemical compound CCCCC\C=C/C\C=C/C\C=C/C\C=C/CCCC(O)=O YZXBAPSDXZZRGB-DOFZRALJSA-N 0.000 description 2
- 235000010323 ascorbic acid Nutrition 0.000 description 2
- 229960005070 ascorbic acid Drugs 0.000 description 2
- 239000011668 ascorbic acid Substances 0.000 description 2
- 239000007853 buffer solution Substances 0.000 description 2
- 229960001948 caffeine Drugs 0.000 description 2
- VJEONQKOZGKCAK-UHFFFAOYSA-N caffeine Natural products CN1C(=O)N(C)C(=O)C2=C1C=CN2C VJEONQKOZGKCAK-UHFFFAOYSA-N 0.000 description 2
- 230000003833 cell viability Effects 0.000 description 2
- 238000012258 culturing Methods 0.000 description 2
- 230000003013 cytotoxicity Effects 0.000 description 2
- 231100000135 cytotoxicity Toxicity 0.000 description 2
- VHJLVAABSRFDPM-QWWZWVQMSA-N dithiothreitol Chemical compound SC[C@@H](O)[C@H](O)CS VHJLVAABSRFDPM-QWWZWVQMSA-N 0.000 description 2
- HHEAADYXPMHMCT-UHFFFAOYSA-N dpph Chemical compound [O-][N+](=O)C1=CC([N+](=O)[O-])=CC([N+]([O-])=O)=C1[N]N(C=1C=CC=CC=1)C1=CC=CC=C1 HHEAADYXPMHMCT-UHFFFAOYSA-N 0.000 description 2
- 230000001747 exhibiting effect Effects 0.000 description 2
- 238000009472 formulation Methods 0.000 description 2
- 230000007760 free radical scavenging Effects 0.000 description 2
- 230000002757 inflammatory effect Effects 0.000 description 2
- 239000005445 natural material Substances 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000002985 plastic film Substances 0.000 description 2
- 230000035755 proliferation Effects 0.000 description 2
- 239000000377 silicon dioxide Substances 0.000 description 2
- PWRIIDWSQYQFQD-UHFFFAOYSA-N sisunine Natural products CC1CCC2(NC1)OC3CC4C5CCC6CC(CCC6(C)C5CCC4(C)C3C2C)OC7OC(CO)C(OC8OC(CO)C(O)C(OC9OC(CO)C(O)C(O)C9OC%10OC(CO)C(O)C(O)C%10O)C8O)C(O)C7O PWRIIDWSQYQFQD-UHFFFAOYSA-N 0.000 description 2
- 239000000126 substance Substances 0.000 description 2
- 230000002195 synergetic effect Effects 0.000 description 2
- XYNPYHXGMWJBLV-OFMODGJOSA-N tomatidine Natural products O[C@@H]1C[C@H]2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]5[C@@H](C)[C@]6(O[C@H]5C4)NC[C@@H](C)CC6)CC3)CC2)CC1 XYNPYHXGMWJBLV-OFMODGJOSA-N 0.000 description 2
- MUMGGOZAMZWBJJ-JQSYSRDDSA-N (8r,9s,10r,13s,14s,17s)-17-hydroxy-10,13-dimethyl-1,2,6,7-tetratritio-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical compound C1C[C@]2(C)[C@@H](O)CC[C@H]2[C@@H]2C([3H])C([3H])C3=CC(=O)C([3H])C([3H])[C@]3(C)[C@H]21 MUMGGOZAMZWBJJ-JQSYSRDDSA-N 0.000 description 1
- 229940015975 1,2-hexanediol Drugs 0.000 description 1
- CWVRJTMFETXNAD-FWCWNIRPSA-N 3-O-Caffeoylquinic acid Natural products O[C@H]1[C@@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-FWCWNIRPSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- POJWUDADGALRAB-PVQJCKRUSA-N Allantoin Natural products NC(=O)N[C@@H]1NC(=O)NC1=O POJWUDADGALRAB-PVQJCKRUSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-N Betaine Natural products C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 1
- 241000283690 Bos taurus Species 0.000 description 1
- PZIRUHCJZBGLDY-UHFFFAOYSA-N Caffeoylquinic acid Natural products CC(CCC(=O)C(C)C1C(=O)CC2C3CC(O)C4CC(O)CCC4(C)C3CCC12C)C(=O)O PZIRUHCJZBGLDY-UHFFFAOYSA-N 0.000 description 1
- 102000008186 Collagen Human genes 0.000 description 1
- 108010035532 Collagen Proteins 0.000 description 1
- 241000196324 Embryophyta Species 0.000 description 1
- OYHQOLUKZRVURQ-HZJYTTRNSA-N Linoleic acid Chemical compound CCCCC\C=C/C\C=C/CCCCCCCC(O)=O OYHQOLUKZRVURQ-HZJYTTRNSA-N 0.000 description 1
- KWIUHFFTVRNATP-UHFFFAOYSA-O N,N,N-trimethylglycinium Chemical compound C[N+](C)(C)CC(O)=O KWIUHFFTVRNATP-UHFFFAOYSA-O 0.000 description 1
- AFCARXCZXQIEQB-UHFFFAOYSA-N N-[3-oxo-3-(2,4,6,7-tetrahydrotriazolo[4,5-c]pyridin-5-yl)propyl]-2-[[3-(trifluoromethoxy)phenyl]methylamino]pyrimidine-5-carboxamide Chemical compound O=C(CCNC(=O)C=1C=NC(=NC=1)NCC1=CC(=CC=C1)OC(F)(F)F)N1CC2=C(CC1)NN=N2 AFCARXCZXQIEQB-UHFFFAOYSA-N 0.000 description 1
- ACFIXJIJDZMPPO-NNYOXOHSSA-N NADPH Chemical compound C1=CCC(C(=O)N)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OC[C@@H]2[C@H]([C@@H](OP(O)(O)=O)[C@@H](O2)N2C3=NC=NC(N)=C3N=C2)O)O1 ACFIXJIJDZMPPO-NNYOXOHSSA-N 0.000 description 1
- CWVRJTMFETXNAD-KLZCAUPSSA-N Neochlorogenin-saeure Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O CWVRJTMFETXNAD-KLZCAUPSSA-N 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- VMHLLURERBWHNL-UHFFFAOYSA-M Sodium acetate Chemical compound [Na+].CC([O-])=O VMHLLURERBWHNL-UHFFFAOYSA-M 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 102000009822 Sterol Regulatory Element Binding Proteins Human genes 0.000 description 1
- 108010020396 Sterol Regulatory Element Binding Proteins Proteins 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000607479 Yersinia pestis Species 0.000 description 1
- 230000003187 abdominal effect Effects 0.000 description 1
- JYYQHHRSFZMKIN-UHFFFAOYSA-N acetic acid;cyclohexane Chemical compound CC(O)=O.C1CCCCC1 JYYQHHRSFZMKIN-UHFFFAOYSA-N 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 229960000458 allantoin Drugs 0.000 description 1
- 230000003712 anti-aging effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 235000021016 apples Nutrition 0.000 description 1
- 229940114079 arachidonic acid Drugs 0.000 description 1
- 235000021342 arachidonic acid Nutrition 0.000 description 1
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 229960003237 betaine Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- CWVRJTMFETXNAD-JUHZACGLSA-N chlorogenic acid Chemical compound O[C@@H]1[C@H](O)C[C@@](O)(C(O)=O)C[C@H]1OC(=O)\C=C\C1=CC=C(O)C(O)=C1 CWVRJTMFETXNAD-JUHZACGLSA-N 0.000 description 1
- 229940074393 chlorogenic acid Drugs 0.000 description 1
- FFQSDFBBSXGVKF-KHSQJDLVSA-N chlorogenic acid Natural products O[C@@H]1C[C@](O)(C[C@@H](CC(=O)C=Cc2ccc(O)c(O)c2)[C@@H]1O)C(=O)O FFQSDFBBSXGVKF-KHSQJDLVSA-N 0.000 description 1
- 235000001368 chlorogenic acid Nutrition 0.000 description 1
- 150000001840 cholesterol esters Chemical class 0.000 description 1
- BMRSEYFENKXDIS-KLZCAUPSSA-N cis-3-O-p-coumaroylquinic acid Natural products O[C@H]1C[C@@](O)(C[C@@H](OC(=O)C=Cc2ccc(O)cc2)[C@@H]1O)C(=O)O BMRSEYFENKXDIS-KLZCAUPSSA-N 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- 229920001436 collagen Polymers 0.000 description 1
- 150000001875 compounds Chemical class 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 239000013068 control sample Substances 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 229940008099 dimethicone Drugs 0.000 description 1
- 239000004205 dimethyl polysiloxane Substances 0.000 description 1
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 1
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229930004069 diterpene Natural products 0.000 description 1
- 150000004141 diterpene derivatives Chemical class 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 239000000686 essence Substances 0.000 description 1
- 229940011871 estrogen Drugs 0.000 description 1
- 239000000262 estrogen Substances 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 210000002950 fibroblast Anatomy 0.000 description 1
- DBEPLOCGEIEOCV-WSBQPABSSA-N finasteride Chemical compound N([C@@H]1CC2)C(=O)C=C[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H](C(=O)NC(C)(C)C)[C@@]2(C)CC1 DBEPLOCGEIEOCV-WSBQPABSSA-N 0.000 description 1
- 229960004039 finasteride Drugs 0.000 description 1
- 229930003935 flavonoid Natural products 0.000 description 1
- 150000002215 flavonoids Chemical class 0.000 description 1
- 235000017173 flavonoids Nutrition 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 239000008269 hand cream Substances 0.000 description 1
- FHKSXSQHXQEMOK-UHFFFAOYSA-N hexane-1,2-diol Chemical compound CCCCC(O)CO FHKSXSQHXQEMOK-UHFFFAOYSA-N 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 208000027866 inflammatory disease Diseases 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000002917 insecticide Substances 0.000 description 1
- 230000009545 invasion Effects 0.000 description 1
- 229940119170 jojoba wax Drugs 0.000 description 1
- OYHQOLUKZRVURQ-IXWMQOLASA-N linoleic acid Natural products CCCCC\C=C/C\C=C\CCCCCCCC(O)=O OYHQOLUKZRVURQ-IXWMQOLASA-N 0.000 description 1
- 235000020778 linoleic acid Nutrition 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 238000002844 melting Methods 0.000 description 1
- 230000008018 melting Effects 0.000 description 1
- 244000005700 microbiome Species 0.000 description 1
- 235000013336 milk Nutrition 0.000 description 1
- 239000008267 milk Substances 0.000 description 1
- 210000004080 milk Anatomy 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 229930027945 nicotinamide-adenine dinucleotide Natural products 0.000 description 1
- 231100000252 nontoxic Toxicity 0.000 description 1
- 230000003000 nontoxic effect Effects 0.000 description 1
- 239000003921 oil Substances 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 239000001301 oxygen Substances 0.000 description 1
- 229910052760 oxygen Inorganic materials 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 1
- 239000003755 preservative agent Substances 0.000 description 1
- 230000002335 preservative effect Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 1
- 210000002307 prostate Anatomy 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 230000005070 ripening Effects 0.000 description 1
- 238000007665 sagging Methods 0.000 description 1
- 239000012488 sample solution Substances 0.000 description 1
- 210000004761 scalp Anatomy 0.000 description 1
- 210000001732 sebaceous gland Anatomy 0.000 description 1
- 210000004378 sebocyte Anatomy 0.000 description 1
- 239000002453 shampoo Substances 0.000 description 1
- 239000000344 soap Substances 0.000 description 1
- 239000001632 sodium acetate Substances 0.000 description 1
- 235000017281 sodium acetate Nutrition 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 238000013222 sprague-dawley male rat Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 238000007447 staining method Methods 0.000 description 1
- 239000012192 staining solution Substances 0.000 description 1
- 239000000021 stimulant Substances 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 239000004094 surface-active agent Substances 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- DCXXMTOCNZCJGO-UHFFFAOYSA-N tristearoylglycerol Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCC(OC(=O)CCCCCCCCCCCCCCCCC)COC(=O)CCCCCCCCCCCCCCCCC DCXXMTOCNZCJGO-UHFFFAOYSA-N 0.000 description 1
- 210000002229 urogenital system Anatomy 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 150000003722 vitamin derivatives Chemical class 0.000 description 1
- 239000000341 volatile oil Substances 0.000 description 1
- 239000000080 wetting agent Substances 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/008—Preparations for oily skin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/40—Chemical, physico-chemical or functional or structural properties of particular ingredients
- A61K2800/52—Stabilizers
- A61K2800/522—Antioxidants; Radical scavengers
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Microbiology (AREA)
- Birds (AREA)
- Epidemiology (AREA)
- Mycology (AREA)
- Botany (AREA)
- Biotechnology (AREA)
- Engineering & Computer Science (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
본 발명은 천연복합추출물을 유효성분으로 함유하는 화장료 조성물에 관한 것으로서, 보다 상세하게는 풋사과, 그린커피빈, 그린토마토 및 사발팜 열매 복합추출물을 유효성분으로 함유하여 우수한 항산화, 모공수축(수렴) 및 피지 분비 억제효과를 나타내는 화장료 조성물에 관한 것이다.The present invention relates to a cosmetic composition containing a natural complex extract as an active ingredient, and more particularly, contains a green apple, green coffee bean, green tomato and saba palm fruit complex extract as an active ingredient to provide excellent antioxidant and pore contraction (convergence) And it relates to a cosmetic composition exhibiting a sebum secretion inhibitory effect.
일반적으로 두피 및 얼굴 등을 포함하는 피부에서 피지의 생성은 피부의 보습 유지나 미생물의 침입을 막는 역할을 담당하지만, 피지의 과다한 분비는 피부의 번들거림이나 화장의 들뜸, 모공의 확대와 노화, 사춘기 이후 여드름의 생성 촉진 등을 유발하기도 한다. 피지의 과다한 분비에는 여러 가지 원인이 관여하고 있는데 그 중에서도 호르몬의 작용에 의한 피지선 세포의 활성화로 인한 원인이 가장 주요한 요인으로 알려져 있다. 이에, 종래 남성 호르몬에 의해 유발되는 피지의 과다 분비나 여드름 치료를 위해 에스트로겐 등의 여성 호르몬을 사용하였지만, 피부 염증 발생, 호르몬 투여에 의한 부작용 등으로 현재는 사용을 중단하거나 아주 극미량을 사용하고 있는 실정이다. 현재 화장품에서 피지 분비를 억제하는 방법으로는 일시적으로 피지를 흡착시키는 다공성 파우더를 활용하거나 기존에 피지를 억제한다고 알려져 있는 추출물 등을 활용하는 방법이 있으나, 그 활성성분의 함량이 미량이라 효과는 미미한 정도이다.In general, the production of sebum in the skin, including the scalp and face, plays a role in maintaining moisture in the skin and preventing the invasion of microorganisms, but excessive secretion of sebum causes shine of the skin, lifting of makeup, enlargement of pores and aging, and post-puberty. It can also trigger the formation of acne. Various causes are involved in the excessive secretion of sebum, and among them, the cause caused by the activation of sebaceous gland cells by the action of hormones is known to be the most important factor. Accordingly, female hormones such as estrogen have been used to treat excessive secretion of sebum or acne caused by male hormones in the past, but due to skin inflammation and side effects caused by hormone administration, the use is currently discontinued or a very small amount is used. The situation is. Currently, as a method of suppressing sebum secretion in cosmetics, there are methods of using porous powder that temporarily absorbs sebum or using extracts known to inhibit sebum, but the effect is insignificant due to the small amount of active ingredients. is about
본 발명자들은 모공케어의 핵심이 호르몬 작용으로 인한 과도한 피지 생성 저해와 그에 의해 늘어난 모공 수축임을 착안하여 피지 생성을 촉진하는 효소인 5α-reductase의 활성을 저해하는 천연물과 수렴작용을 통해 피부 모공을 수축시켜주는 천연물을 이용하는 천연 모공축소 및 피지조절용 화장료의 개발을 위해 연구를 하였으며, 풋사과, 그린커피빈, 그린토마토 및 사발팜 열매의 복합추출물이 피지 생성을 촉진하는 5α-reductase 활성저해능이 우수하며, 우수한 수렴작용으로 모공수축 효과를 나타내는 것을 확인하여 본 발명을 완성하였다.The present inventors conceived that the core of pore care is the inhibition of excessive sebum production due to hormone action and the contraction of enlarged pores, so that they contracted skin pores through astringent action with a natural substance that inhibits the activity of 5α-reductase, an enzyme that promotes sebum production. Research has been conducted to develop cosmetics for natural pore reduction and sebum control using natural substances that help, and the complex extracts of green apple, green coffee bean, green tomato and sabal palm fruit are excellent in inhibiting the activity of 5α-reductase that promotes sebum production, The present invention was completed by confirming that the pore shrinking effect was exhibited by excellent astringent action.
본 발명은 풋사과, 그린커피빈, 그린토마토 및 사발팜 열매의 복합추출물을 유효성분으로 함유하여 우수한 항산화 효과, 피지분비 억제 및 모공수축 효과를 나타내는 화장료 조성물을 제공하는 것을 목적으로 한다.An object of the present invention is to provide a cosmetic composition containing a complex extract of green apple, green coffee bean, green tomato and saba palm fruit as an active ingredient and exhibiting excellent antioxidant effect, sebum secretion inhibition and pore contraction effect.
상기 목적을 달성하기 위하여 본 발명에 따르면, 풋사과, 그린커피빈, 그린토마토 및 사발팜 열매 복합추출물을 유효성분으로 함유하는 화장료 조성물이 제공된다.According to the present invention in order to achieve the above object, there is provided a cosmetic composition containing green apple, green coffee bean, green tomato and fruit complex extract of sabal palm as an active ingredient.
바람직하게는, 상기 복합추출물은 풋사과, 그린커피빈, 그린토마토 및 사발팜 열매를 20~25℃의 저온과 90~100℃의 고온으로 각각 추출한 추출물의 혼합물인 것임을 특징으로 한다. 상기 복합추출물은 상기 저온 추출물과 상기 고온 추출물이 각각 1~3:1~3의 중량비율로 혼합되어 이루어진다.Preferably, the composite extract is characterized in that it is a mixture of extracts extracted from green apple, green coffee bean, green tomato and sabal palm fruit at a low temperature of 20 to 25 ° C and a high temperature of 90 to 100 ° C, respectively. The composite extract is made by mixing the low-temperature extract and the high-temperature extract in a weight ratio of 1 to 3:1 to 3, respectively.
상기 복합추출물은 풋사과, 그린커피빈, 그린토마토 및 사발팜 열매가 각각 0.5~1:0.5~1:0.5~1:0.5~1의 중량비율로 혼합되어 추출되는 것임을 특징으로 한다.The composite extract is characterized in that green apple, green coffee bean, green tomato and sabal palm fruit are mixed and extracted in a weight ratio of 0.5 to 1:0.5 to 1:0.5 to 1:0.5 to 1, respectively.
유효성분으로서 상기 복합추출물은 화장료 조성물 전체 중량에 대하여 0.01~20 중량% 함유된다. As an active ingredient, the composite extract is contained in an amount of 0.01 to 20% by weight based on the total weight of the cosmetic composition.
상기 화장료 조성물은 항산화용, 피지 분비 억제용 또는 모공 수축용인 것을 특징으로 한다. The cosmetic composition is characterized in that it is for antioxidant, sebum secretion inhibition or pore contraction.
본 발명의 풋사과, 그린커피빈, 그린토마토, 사발팜 열매의 천연복합추출물은 천연추출물로서 안전하며, 그 상승효과에 의해 우수한 항산화 효과, 피지분비억제 및 모공 수축(수렴) 효과를 나타내므로 화장료로 유용하게 사용될 수 있다.The natural complex extract of green apple, green coffee bean, green tomato, and sabal palm fruit of the present invention is safe as a natural extract, and exhibits excellent antioxidant effect, sebum secretion inhibition, and pore contraction (convergence) effect due to its synergistic effect, so it can be used as a cosmetic can be useful
도 1은 본 발명의 실시예에 따른 복합추출물의 피지분비 조절 효과를 나타내는 그래프이다.1 is a graph showing the sebum secretion control effect of the composite extract according to an embodiment of the present invention.
이하 본 발명을 상세하게 설명한다.Hereinafter, the present invention will be described in detail.
본 발명은 풋사과, 그린커피빈, 그린토마토 및 사발팜 열매의 복합추출물이 그 상승효과에 의하여 우수한 항산화 효과, 모공 수축효과 및 피지 분비조절효과를 나타낸다는 것을 기술적 특징으로 한다.The technical feature of the present invention is that the composite extract of green apple, green coffee bean, green tomato and saba palm fruit exhibits excellent antioxidant effect, pore contraction effect and sebum secretion control effect due to its synergistic effect.
풋사과는 빨갛게 익기 전에 푸릇한 상태의 사과를 의미한다. 풋사과는 항산화물질인 폴리페놀이 일반 사과에 비해 약 10배 정도 많이 포함되어 있어 노화의 주범인 활성산소를 제거해주어 노화방지 효과가 탁월하다. 풋사과에서 유래된 폴리페놀인 애플페논은 염증인자 NO 생성을 억제하여 피부를 보호 및 진정시켜 주며 피지 생성에 관여하는 단백질인 SREBP 1을 억제한다고 밝혀졌다.A green apple means an apple that is green before ripening to red. Green apples contain about 10 times more polyphenols, which are antioxidants, than regular apples, so they have excellent anti-aging effects by removing active oxygen, the main culprit of aging. It has been found that applephenone, a polyphenol derived from green apples, protects and soothes the skin by suppressing the production of inflammatory factor NO, and suppresses SREBP 1, a protein involved in sebum production.
그린커피빈은 로스팅이 되지 않은 생두를 의미하며 그린커피빈에는 강력한 항산화제인 카페인과 더불어 클로로겐산, 디터펜, 멜라노이딘 등 유익한 화합물이 함유되어 있다. 카페인은 식물을 먹고 사는 해충을 죽이는 살충제 역할을 하는 보호 성분으로 체내 염증 발생 매개체의 생산을 줄여 피부 염증개선에 도움 및 수렴작용을 통해 모공을 축소시켜준다.Green coffee beans refer to green coffee beans that have not been roasted, and green coffee beans contain beneficial compounds such as chlorogenic acid, diterpene, and melanoidin, as well as caffeine, a powerful antioxidant. Caffeine is a protective ingredient that acts as an insecticide that kills pests that feed on plants. It helps improve skin inflammation by reducing the production of inflammatory mediators in the body and shrinks pores through astringent action.
초록빛을 띠는 그린토마토는 근육 노화를 일으키는 단백질을 억제하는 토마티딘을 함유하고 있다. 토마티딘은 모공 주변의 콜라겐 합성을 도와 쳐진 모공을 개선 특히 세로모공 개선 효과가 탁월하다. 또한 열처리한 그린토마토의 경우 폴리페놀, 플라보노이드 함량이 높아져 모공개선 효과에 도움을 준다.Green tomatoes with a green light contain tomatidine, which inhibits a protein that causes muscle aging. Tomatidine helps to synthesize collagen around the pores and improves sagging pores, especially the effect of improving vertical pores. In addition, in the case of heat-treated green tomatoes, the content of polyphenols and flavonoids increases, helping to improve the pores.
사발팜 열매는 18세기 초에 일찍이 아메리카 원주민 남성의 비뇨생식기 계통의 질병을 치료하기 위해 음식물이나 약재로 사용되었으며 건조한 환경에서 자라나 다양한 유효성분을 함유하고 있어 항염, 진정 등에 도움을 준다. 피지 분비의 원인인 5α-Reductase 활성을 억제하여 염증성 질병에 효과적이다.Sabal palm fruit was used as a food or medicine to treat diseases of the genitourinary system of Native American men early in the 18th century, and it grows in a dry environment and contains various active ingredients to help with anti-inflammatory and soothing. It is effective for inflammatory diseases by inhibiting the activity of 5α-Reductase, which is the cause of sebum secretion.
본 발명에 따르면, 풋사과, 그린커피빈, 그린토마토 및 사발팜 열매의 복합추출물을 유효성분으로 함유하는 화장료 조성물이 제공된다.According to the present invention, there is provided a cosmetic composition containing a complex extract of green apple, green coffee bean, green tomato and fruit of sabal palm as an active ingredient.
상기 복합추출물의 제조에는 물, 에탄올, 메탄올, 부탄올, 프로판올, 부틸렌글리콜, 글리세린, 클로로포름, 에틸아세테이트, 디클로로메탄, 헥산, 아세톤, 아세토나이트릴, 페트로레움에테르 및 디에틸에테르로 이루어진 군으로부터 선택된 적어도 하나의 용매를 사용할 수 있다.In the preparation of the composite extract, selected from the group consisting of water, ethanol, methanol, butanol, propanol, butylene glycol, glycerin, chloroform, ethyl acetate, dichloromethane, hexane, acetone, acetonitrile, petroleum ether and diethyl ether At least one solvent may be used.
더욱 바람직하게는, 상기 복합추출물은 풋사과, 그린커피빈, 그린토마토 및 사발팜 열매를 20~25℃의 저온과 90~100℃의 고온으로 각각 추출한 추출물의 혼합물인 것임을 특징으로 한다. 상기 복합추출물은 상기 저온 추출물과 상기 고온 추출물이 각각 1~3:1~3의 중량비율로 혼합되어 이루어진다.More preferably, the complex extract is characterized in that it is a mixture of extracts obtained by extracting green apple, green coffee bean, green tomato, and fruit of sabal palm at a low temperature of 20 to 25 ° C and a high temperature of 90 to 100 ° C, respectively. The composite extract is made by mixing the low-temperature extract and the high-temperature extract in a weight ratio of 1 to 3:1 to 3, respectively.
본 발명의 바람직한 일 구체예에 따르면, 상기 복합추출물은 (A)풋사과, 그린커피빈, 그린토마토 및 사발팜 열매 혼합물에 정제수를 가하여 저온, 바람직하게는 20~25℃의 저온에서 20~24시간 추출하여 저온추출물을 제조하는 단계; (B)풋사과, 그린커피빈, 그린토마토 및 사발팜 열매 혼합물에 정제수를 가하여 고온, 바람직하게는 90~100℃의 고온에서 2~3시간 추출하여 고온추출물을 제조하는 단계; 및 (C)상기 두 추출물을 혼합하는 단계를 포함하는 제조방법에 의하여 제조된다. 각각의 저온추출물, 고온추출물에 비하여 이를 혼합한 상기 복합추출물에서 더욱 우수한 항산화, 피지분비 억제 및 모공수축 효과를 나타내었다.According to a preferred embodiment of the present invention, the composite extract is (A) green apple, green coffee bean, green tomato, and 20 to 24 hours at a low temperature, preferably 20 to 25 ℃ by adding purified water to the palm fruit mixture Extracting to prepare a low-temperature extract; (B) preparing a high-temperature extract by adding purified water to a mixture of green apple, green coffee bean, green tomato and saba palm fruit and extracting at a high temperature, preferably at a temperature of 90 to 100 ° C. for 2 to 3 hours; and (C) mixing the two extracts. Compared to each of the low-temperature extract and the high-temperature extract, the combined extract showed more excellent antioxidant, sebum secretion inhibition, and pore contraction effects.
상기 추출물의 제조에 있어서, 풋사과, 그린커피빈, 그린토마토 및 사발팜 열매는 각각 0.5~1:0.5~1:0.5~1:0.5~1의 중량비율로 혼합되어 추출되며, 각각 1:1:1:1의 중량비율로 혼합되어 추출되는 경우에 더욱 우수한 효과를 나타내므로 더욱 바람직하다.In the preparation of the extract, green apple, green coffee bean, green tomato and sabal palm fruit are mixed and extracted in a weight ratio of 0.5 to 1:0.5 to 1:0.5 to 1:0.5 to 1, respectively, 1:1: It is more preferable because it shows a more excellent effect when mixed and extracted in a weight ratio of 1: 1.
이와 같이 제조되는 본 발명의 복합추출물은 우수한 항산화 활성(시험예 1), 피지 분비 억제 활성(시험예 2, 3) 및 모공 수축 활성(시험예 4)을 나타내었다.The composite extract of the present invention thus prepared exhibited excellent antioxidant activity (Test Example 1), sebum secretion inhibitory activity (Test Examples 2 and 3) and pore contraction activity (Test Example 4).
유효성분으로서의 상기 복합추출물은 화장료 조성물 전체 중량에 대해 0.01~20 중량% 함유된다.The composite extract as an active ingredient is contained in an amount of 0.01 to 20% by weight based on the total weight of the cosmetic composition.
상기 화장료 조성물은 항산화용, 모공 수축용 또는 피지분비 억제용으로 유용하게 사용될 수 있다.The cosmetic composition may be usefully used for antioxidant, pore contraction, or sebum secretion inhibition.
본 발명의 화장료 조성물은 상기 복합추출물에 추가로 지방 물질, 계면활성제, 보존제, 비타민, 습윤화제, 물, 유화제, 필수 오일 또는 화장품에 통상적으로 사용되는 임의의 다른 성분과 같은 화장품학 또는 피부과학 분야에서 통상적으로 사용되는 보조제를 함유할 수 있다. 그리고 상기의 성분들은 피부 과학 분야에서 일반적으로 사용되는 양으로 도입될 수 있다. In addition to the composite extract, the cosmetic composition of the present invention is a cosmetic or dermatological field such as a fatty substance, a surfactant, a preservative, a vitamin, a wetting agent, water, an emulsifier, an essential oil, or any other component commonly used in cosmetics. It may contain commonly used adjuvants. In addition, the above components may be introduced in an amount generally used in the field of skin science.
또한 본 발명에서 상기 화장료 조성물의 제형은 제한되지는 않으나 스킨로션, 스킨 소프너, 스킨토너, 아스트린젠트, 로션, 밀크로션, 모이스쳐 로션, 영양로션, 맛사지 크림, 영양크림, 모이스처 크림, 핸드크림, 에센스, 팩, 비누, 샴푸, 트리트먼트, 클렌징 폼, 클렌징 로션, 클렌징 크림, 바디로션, 바디클렌져, 유액, 프레스파우더, 루스파우더 및 아이새도로 구성된 그룹에서 선택된 어느 하나의 제형으로 적용될 수 있다.In addition, the formulation of the cosmetic composition in the present invention is not limited, but skin lotion, skin softener, skin toner, astringent, lotion, milk lotion, moisture lotion, nutrient lotion, massage cream, nutrient cream, moisture cream, hand cream, essence, It may be applied in any one formulation selected from the group consisting of pack, soap, shampoo, treatment, cleansing foam, cleansing lotion, cleansing cream, body lotion, body cleanser, emulsion, press powder, loose powder, and eye shadow.
[실시예][Example]
이하, 본 발명을 하기 실시예 및 시험예에 의거하여 더욱 상세하게 설명하고자 한다. 단, 하기 실시예는 본 발명을 예시하기 위한 것일 뿐, 본 발명이 하기 실시예에 의해 한정되는 것은 아니다.Hereinafter, the present invention will be described in more detail based on the following examples and test examples. However, the following examples are only for illustrating the present invention, and the present invention is not limited by the following examples.
실시예 1~2: 저온 천연복합추출물 제조Example 1-2: Preparation of low-temperature natural complex extract
풋사과, 그린커피빈, 그린토마토 및 사발팜 열매를 하기 표 1의 비율로 혼합 후 건조 중량의 10배에 해당하는 정제수에 넣고 저온(20~25℃)에서 24시간 추출하였다. 이를 감압 농축기를 이용하여 50~60℃의 온도에서 농축한 후 동결건조기로 동결 건조하여 추출분말을 얻었다.After mixing green apples, green coffee beans, green tomatoes, and Sabal palm fruits in the ratio shown in Table 1 below, they were put in purified water corresponding to 10 times the dry weight and extracted at low temperature (20-25 ° C) for 24 hours. This was concentrated at a temperature of 50 to 60 ° C using a vacuum concentrator and then freeze-dried with a lyophilizer to obtain an extracted powder.
실시예 3~4: 고온 천연복합추출물 제조Examples 3-4: Preparation of high-temperature natural complex extract
풋사과, 그린커피빈, 그린토마토 및 사발팜 열매를 하기 표 2의 비율로 혼합 후 건조 중량의 10배에 해당하는 정제수에 넣고 고온(90~100℃)에서 2시간 추출하였다. 이를 감압 농축기를 이용하여 50~60℃의 온도에서 농축한 후 동결건조기로 동결 건조하여 추출분말을 얻었다.After mixing green apples, green coffee beans, green tomatoes, and Sabal palm fruits in the ratio shown in Table 2 below, they were put in purified water corresponding to 10 times the dry weight and extracted at high temperature (90 ~ 100 ℃) for 2 hours. This was concentrated at a temperature of 50 to 60 ° C using a vacuum concentrator and then freeze-dried with a lyophilizer to obtain an extracted powder.
실시예 5~6: 천연복합추출물의 제조Examples 5-6: Preparation of natural complex extract
상기 실시예에서 제조된 풋사과, 그린커피빈, 그린토마토 및 사발팜 열매의 저온 복합추출물과 고온 복합추출물을 동일 중량비율로 혼합하여 각각 실시예 5(실시예 1 + 실시예 3), 실시예 6(실시예 2 + 실시예 4)으로 하였다.The low-temperature composite extract and the high-temperature composite extract of green apple, green coffee bean, green tomato, and saba palm fruit prepared in the above example were mixed in the same weight ratio to Example 5 (Example 1 + Example 3) and Example 6, respectively. (Example 2 + Example 4).
비교예 1: 저온 천연복합추출물 제조Comparative Example 1: Preparation of low-temperature natural complex extract
풋사과, 그린커피빈 및 그린토마토를 하기 표 3의 비율로 혼합 후 건조 중량의 10배에 해당하는 정제수에 넣고 저온(20~25℃)에서 24시간 추출하였다. 이를 감압 농축기를 이용하여 50~60℃의 온도에서 농축한 후 동결건조기로 동결 건조하여 추출분말을 얻었다.After mixing green apples, green coffee beans, and green tomatoes in the ratio shown in Table 3 below, they were put in purified water corresponding to 10 times the dry weight and extracted at low temperature (20-25 ° C) for 24 hours. This was concentrated at a temperature of 50 to 60 ° C using a vacuum concentrator and then freeze-dried with a lyophilizer to obtain an extracted powder.
비교예 2: 고온 천연복합추출물 제조Comparative Example 2: Preparation of high-temperature natural complex extract
풋사과, 그린커피빈 및 그린토마토를 하기 표 4의 비율로 혼합 후 건조 중량의 10배에 해당하는 정제수에 넣고 고온(90~100℃)에서 2시간 추출하였다. 이를 감압 농축기를 이용하여 50~60℃의 온도에서 농축한 후 동결건조기로 동결 건조하여 추출분말을 얻었다.Green apples, green coffee beans, and green tomatoes were mixed in the ratio shown in Table 4 below, put in purified water corresponding to 10 times the dry weight, and extracted at high temperature (90-100 ° C) for 2 hours. This was concentrated at a temperature of 50 to 60 ° C using a vacuum concentrator and then freeze-dried with a lyophilizer to obtain an extracted powder.
비교예 3: 천연복합추출물의 제조Comparative Example 3: Preparation of natural complex extract
상기 비교예 1, 2에서 제조된 풋사과, 그린커피빈 및 그린토마토의 저온 복합추출물과 고온 복합추출물을 동일 중량비율로 혼합하여 비교예 3으로 하였다.Comparative Example 3 was obtained by mixing the low-temperature composite extract and the high-temperature composite extract of green apple, green coffee bean, and green tomato prepared in Comparative Examples 1 and 2 in the same weight ratio.
시험예 1: 항산화 효과Test Example 1: Antioxidant effect
상기 비교예와 실시예에 따른 추출물들의 DPPH free radical 소거능을 측정하였다.The DPPH free radical scavenging ability of the extracts according to the comparative examples and examples was measured.
각 실시예 및 비교예 시료 용액 0.1mL와 DPPH(1,1-diphenyl-2-picrylhydrazyl) 용액 0.1 mL를 혼합 후 30분 동안 방치한 다음, ELISA Reader를 이용하여 520nm에서 시료의 라디칼 소거 활성을 평가하였다. 이 때 양성 대조군으로는 Ascorbic acid를 사용하였으며, 하기의 식으로 DPPH 라디칼 소거 활성을 계산하였다. 결과는 하기 표 5에 나타내었다.After mixing 0.1 mL of the sample solution of each Example and Comparative Example and 0.1 mL of DPPH (1,1-diphenyl-2-picrylhydrazyl) solution, leave it for 30 minutes, and then evaluate the radical scavenging activity of the sample at 520 nm using an ELISA Reader. did At this time, ascorbic acid was used as a positive control, and DPPH radical scavenging activity was calculated by the following formula. The results are shown in Table 5 below.
DPPH 라디칼 소거 활성(%)= [(control-sample)/control]×100DPPH radical scavenging activity (%) = [(control-sample)/control] × 100
상기 표 5에 나타난 바와 같이, 풋사과, 그린커피빈, 그린토마토 및 사발팜 열매의 복합추출물은 비교예의 풋사과, 그린커피빈 및 그린토마토 복합추출물에 비하여 보다 우수한 DPPH 라디칼 소거능을 나타내었으며, 저온 추출물과 고온 추출물을 혼합하여 제조된 실시예 5, 실시예 6의 복합추출물에서 가장 우수한 DPPH 라디칼 소거능을 나타내어 항산화 능력이 가장 우수한 것으로 확인되었다. 대조군인 Ascorbic acid(50ppm)의 경우 86.03%의 소거율을 나타내었다.As shown in Table 5, the composite extract of green apple, green coffee bean, green tomato, and fruit of Sabal palm exhibited better DPPH radical scavenging activity than the green apple, green coffee bean, and green tomato composite extract of Comparative Example, and the low-temperature extract and The composite extracts of Examples 5 and 6 prepared by mixing the high-temperature extracts showed the best DPPH radical scavenging ability, and thus it was confirmed that the antioxidant ability was the best. Ascorbic acid (50ppm), the control group, showed a clearance rate of 86.03%.
시험예 2: 피지 조절 효능Test Example 2: Sebum control efficacy
Oil Red O staining method를 통해 세포 안의 중성지질(triacylglycerol, cholesterol ester)을 염색하는 방법으로 세포를 염색하여 각 추출물의 피지 조절 효능을 이미지로 비교하거나 isoprotanol에 녹인 후 흡광도로 비교하였다.Cells were stained by staining the neutral lipids (triacylglycerol, cholesterol ester) inside the cells through the Oil Red O staining method, and the sebum control efficacy of each extract was compared with images or after dissolving in isoprotanol, the absorbance was compared.
구체적으로, primary sebocyte를 6 × 10⁴cells/well의 농도로 24 well 플레이트에 분주하고 하룻밤 동안 배양하였다. 피지 분비를 촉진시키기 위해 linoleic acid(50 μM), arachidonic acid(50 μM), dihydrotestosterone(50 nM)을 자극원으로 처리하고, 상기 비교예와 실시예에서 제조한 각 추출물을 처리하지 않거나 함께 처리하여 4일 동안 배양한 후에 배지를 제거하고 PBS로 세척하였다. 이후, PBS 내의 10% 파라포름알데하이드를 넣어 15분간 세포를 고정시킨 후 다시 PBS로 세척하였다. Oil Red O 염색 용액을 15분간 처리하고 EtOH와 DIW로 세척하여 과도한 염색약을 제거한 다음 PBS에 넣어 현미경 관찰을 하고, PBS를 제거한 후 이소프로필 알코올 내의 4% NP-40을 넣어 세포에 염색된 염색약을 녹여 흡광도 520 nm에서 측정하였으며 중성지질 생성 정도를 비자극군(추출물 비처리군)을 기준으로 % 비교하여 피지 조절 효능을 평가하였다.Specifically, primary sebocytes were dispensed into a 24-well plate at a concentration of 6 × 10⁴cells/well and cultured overnight. In order to promote sebum secretion, linoleic acid (50 μM), arachidonic acid (50 μM), and dihydrotestosterone (50 nM) were treated as stimulants, and each extract prepared in Comparative Examples and Examples was not treated or treated together. After culturing for 4 days, the medium was removed and washed with PBS. Thereafter, 10% paraformaldehyde in PBS was added to fix the cells for 15 minutes, and then the cells were washed again with PBS. Oil Red O staining solution was treated for 15 minutes, washed with EtOH and DIW to remove excess dye, put into PBS for microscopic observation, and after removing PBS, 4% NP-40 in isopropyl alcohol was added to dye the cells. After melting, the absorbance was measured at 520 nm, and the degree of neutral lipid production was compared by % based on the non-stimulated group (extract non-treated group) to evaluate the sebum control effect.
그 결과, 양성 대조군인 Induction Control 군이 중성지질 생성량을 증가시키는 것에 반해 비교예와 실시예의 시료는 피지 분비 촉진 작용에도 중성지질 생성량을 감소시켰다. 특히 비교예에 비해 실시예에서 더 뛰어난 피지 억제 효능을 나타내는 것을 확인하였다(도 1).As a result, while the Induction Control group, which is a positive control group, increased the production of neutral lipids, the samples of Comparative Examples and Examples decreased the production of neutral lipids despite the sebum secretion promoting action. In particular, it was confirmed that the examples showed a more excellent sebum inhibitory effect than the comparative example (FIG. 1).
시험예 3: 피지 분비 억제 실험Test Example 3: Sebum secretion inhibition test
상기 비교예와 실시예에 따른 추출물 시료의 5α-리덕타아제 활성 저해율을 측정하였다.The 5α-reductase activity inhibition rate of the extract samples according to the comparative examples and examples was measured.
24시간 절식시킨 성숙한 Sprague-Dawley 웅성랫트(생후 7~8주)를 디에틸에테르로 치사시킨 후, 복부 전립선을 떼내어 결합조직을 제거하였다. 여기에 완충액(0.32M 슈크로오즈(sucrose), 0.1mM 디티오트레이톨(dithiothreitol), 20mM 소디움아세테이트(sodium acetate))를 첨가하여 잘게 자른 다음, 분쇄기로 현탁화하였다. 현탁액을 원심분리하여 상층액을 취하여 5α-리덕타아제를 부분정제하였다. 이 효소를 이용하여 활성도 억제실험을 수행하였다.Adult Sprague-Dawley male rats (7-8 weeks old) fasted for 24 hours were killed with diethyl ether, and then the abdominal prostate was removed and the connective tissue was removed. A buffer solution (0.32M sucrose, 0.1mM dithiothreitol, 20mM sodium acetate) was added thereto, chopped into small pieces, and then suspended using a grinder. The suspension was centrifuged to obtain a supernatant to partially purify 5α-reductase. An activity inhibition experiment was performed using this enzyme.
상기 얻어진 상층액의 일부를 취하여 0.2M 일염기산과 0.2M 이염기산이 들어있는 완충액에 넣은 후, 동위원소인 3H가 붙어있는 기질(테스토스테론)과 함께 반응시켜 생성물인 디하이드로테스토스테론의 생성량을 측정하였다. 반응용액은 1mM 디티오트레이톨, 40mM 나트륨 포스페이트(pH 6.5), 50μM NADPH, [1,2,6,7- 3H]테스토스테론/테스토스테론 및 효소현탁액(0.5mg)을 넣어 총 부피가 640μl가 되게 하였다.A portion of the obtained supernatant was placed in a buffer solution containing 0.2M monobasic acid and 0.2M dibasic acid, and then reacted with a substrate (testosterone) to which the isotope 3H was attached to measure the amount of dihydrotestosterone produced. . The reaction solution was prepared by adding 1 mM dithiothreitol, 40 mM sodium phosphate (pH 6.5), 50 μM NADPH, [1,2,6,7-3H] testosterone/testosterone and enzyme suspension (0.5 mg) to a total volume of 640 μl. .
시료는 10% 에탄올에 1%가 되도록 녹인 후, 위의 반응용액에 시료를 6.40μl 첨가하여 최종농도가 0.01%가 되도록 하였다. 대조군으로는 같은 부피의 용매를 이용하였고, 양성대조군으로는 피나스테라이드(Finasteride)라는 미국 FDA의 승인을 받은 5α-리덕타아제의 저해제로서 잘 알려진 물질을 이용하였다.After dissolving the sample to 1% in 10% ethanol, 6.40 μl of the sample was added to the above reaction solution to make the final concentration 0.01%. As a control group, the same volume of solvent was used, and as a positive control group, a well-known substance called finasteride, an inhibitor of 5α-reductase approved by the US FDA, was used.
반응은 효소 현탁액을 부가함과 동시에 시작하여 37℃에서 30분간 진행시킨 후, 1ml의 에틸아세테이트를 가하여 추출하였으며, 100μl의 에틸아세테이트상을 실리카 플라스틱시트 카이젤겔 60F 254 (Silica plastic sheet kieselgel F254)상에서 전개용매계는 아세테이트-사이클로헥산(1:1)으로 하여 전개하였다.The reaction was started simultaneously with the addition of the enzyme suspension and proceeded at 37 ° C. for 30 minutes, followed by extraction by adding 1 ml of ethyl acetate, and 100 μl of ethyl acetate was applied to silica plastic sheet kieselgel F254 (Silica plastic sheet kieselgel F254). The developing solvent system was developed with acetate-cyclohexane (1:1).
플라스틱 시료를 공기 중에서 건조한 후, 동위원소의 양을 측정하기 위해 바스 시스템을 사용하였는데, 건조된 플라스틱 시트와 엑스레이 필름을 함께 바스 카셋트에 넣어 1주일 후에 필름에 잔존해 있는 테스토스테론과 디하이드로테스토스테론의 동위원소양을 측정하였다. 각각의 저해율에 대한 결과는 하기 표 6에 나타내었다.After drying the plastic sample in the air, a bath system was used to measure the amount of isotope. The elemental content was measured. The results for each inhibition rate are shown in Table 6 below.
* T : 테스토스테론 영역에서 나타난 3H 방사능(Radio Activity)* T: 3H radioactivity in testosterone area (Radio Activity)
** DHT : 디하이드로테스토스테론 영역에서 나타난 3H 방사능** DHT: 3H radioactivity in the area of dihydrotestosterone
*** 전환율 : DHT영역에의 방사능 / 총 방사능×100*** Conversion rate: radioactivity to DHT area / total radioactivity × 100
**** 저해율 : ((대조군의 전환율-시료의 전환율) / 대조군의 전환율)×100**** Inhibition rate: ((conversion rate of control group - conversion rate of sample) / conversion rate of control group) × 100
그 결과, 상기 실시예의 풋사과, 그린커피빈, 그린토마토 및 사발팜 열매의 복합추출물은 비교예의 풋사과, 그린커피빈 및 그린토마토 복합추출물에 비하여 보다 우수한 5α-리덕타아제 저해효과를 나타내었으며, 저온 추출물과 고온 추출물을 혼합하여 제조된 실시예 5, 실시예 6의 복합추출물에서 가장 우수한 5α-리덕타아제 저해효과를 나타내어 피지 조절활성이 가장 우수한 것으로 확인되었다.As a result, the composite extract of green apple, green coffee bean, green tomato, and sabal palm fruit of Example showed a more excellent 5α-reductase inhibitory effect than the green apple, green coffee bean, and green tomato composite extract of Comparative Example, and The composite extracts of Examples 5 and 6 prepared by mixing the extract and the high-temperature extract exhibited the best 5α-reductase inhibitory effect, and it was confirmed that the sebum control activity was the best.
시험예 4: 모공 수축 효과 시험Test Example 4: Pore contraction effect test
모공 수축 효과를 시험하기 위하여 상기 비교예와 실시예에 따른 복합추출물 시료를 사용하여 헤모글로빈 침전율을 측정하였다.In order to test the pore contraction effect, the hemoglobin precipitation rate was measured using the composite extract samples according to the Comparative Examples and Examples.
상기 비교예 및 실시예 시료에 대하여 소(bovine) 헤모글로빈 단백질을 이용해서 모공 수축효과를 확인하였다. PBS(phosphate bufferedsaline, pH 7.4)를 헤모글로빈과 1:1로 혼합용액(1 mg/1 ml)을 만들고, 3,000 rpm에서 5분간 원심분리하고, 상등액을 분리하여 광학기기에서 407 nm에서 흡광도를 측정하였다. 대조군으로는 시료 대신 상기 혼합용매 2 ml를 사용했다. 반응액 중에 함유시킨 비교예 및 실시예 시료의 최종 농도가 1 ~ 5 %인 경우에서 헤모글로빈의 침전량을 측정하여 모공수축 효과를 측정하였으며, 그 결과는 표 7과 같았다. 헤모글로빈의 침전율이 높을수록 모공수축 효과가 뛰어나다는 것을 나타낸다.The pore contraction effect was confirmed using bovine hemoglobin protein for the samples of the comparative examples and examples. PBS (phosphate bufferedsaline, pH 7.4) was mixed with hemoglobin at a ratio of 1:1 (1 mg/1 ml), centrifuged at 3,000 rpm for 5 minutes, and the supernatant was separated to measure absorbance at 407 nm using an optical instrument. . As a control, 2 ml of the mixed solvent was used instead of the sample. The pore contraction effect was measured by measuring the amount of hemoglobin precipitated when the final concentration of the samples of Comparative Examples and Examples contained in the reaction solution was 1 to 5%, and the results are shown in Table 7. The higher the hemoglobin precipitation rate, the better the pore shrinking effect.
상기 표 7에서 확인되는 바와 같이 저온 추출물과 고온 추출물을 혼합하여 제조된 실시예 5, 실시예 6의 복합추출물에서 더욱 높은 침전율을 나타내어, 단백질 응고효과를 통한 모공 수축효과가 뛰어남을 확인할 수 있다.As confirmed in Table 7, the composite extracts of Examples 5 and 6 prepared by mixing the low-temperature extract and the high-temperature extract showed a higher precipitation rate, indicating that the pore contraction effect through the protein coagulation effect was excellent.
시험예 5: 세포 독성 및 증식 실험Test Example 5: Cytotoxicity and Proliferation Experiment
세포 독성 및 증식 실험을 다음과 같은 방법으로 실시하였다. 인체 정상 섬유아세포를 96-웰 마이크로플레이트의 각 웰에 1 × 10⁴세포가 되도록 접종하고, DMEM 배지에서 37℃에서 24시간 동안 배양하였다. 이어, 최종 농도를 0.1, 0.5, 1.0, 2.0, 5.0%로 하여 혈청이 2.5% 함유되어 있는 DMEM 배지로 교체한 실험군과 혈청이 없는 DMEM 배지로 교체한 대조군을 24시간 동안 추가로 배양하였다. 배양 후, 세포의 생존율을 비교하기 위하여 MTT(시그마, 미합중국) 솔루션(3mg/ml)을 첨가하여 세포 생존율을 ELISA READER(Molecular Devices, 미합중국)를 이용하여 570nm에서 흡광도를 측정하고 세포 성장의 최적 조건인 위과 같은 조건으로 동시배양을 하였으며, 대조군의 세포증식을 100%로 하고 시료 투입 실험군의 세포 증식률을 계산하였다.Cytotoxicity and proliferation experiments were conducted in the following manner. Normal human fibroblasts were inoculated into each well of a 96-well microplate to form 1 × 10⁴ cells, and cultured in DMEM medium at 37° C. for 24 hours. Subsequently, the experimental group replaced with DMEM medium containing 2.5% serum at a final concentration of 0.1, 0.5, 1.0, 2.0, and 5.0%, and the control group replaced with serum-free DMEM medium were further cultured for 24 hours. After culturing, in order to compare cell viability, MTT (Sigma, United States) solution (3mg/ml) was added and cell viability was measured using ELISA READER (Molecular Devices, United States) to measure absorbance at 570 nm and optimal conditions for cell growth Simultaneous culture was performed under the same conditions as above, and cell proliferation of the control group was set as 100%, and the cell growth rate of the sample input experimental group was calculated.
세포증식률(%)=(시료 첨가군의 O.D at 570nm/시료 무첨가군의 O.D at 570nm) × 100Cell proliferation rate (%) = ( OD at 570 nm of sample-added group/ OD at 570 nm of sample-free group) × 100
상기 표 8에서 나타난 바와 같이, 세포 성장 최적 조건에서의 세포 증식을 100%로 하였을 때, 측정 오차범위를 고려하면 풋사과, 그린커피빈, 그린토마토, 사발팜 열매의 복합추출물은 모두 세포 무독성이며, 세포 증식 효과가 있음을 알 수 있었다.As shown in Table 8, when the cell proliferation in the optimal cell growth conditions is 100%, considering the measurement error range, the composite extracts of green apple, green coffee bean, green tomato, and Sabal palm fruit are all non-toxic to cells, It was found that there was a cell proliferation effect.
실시예 7: 천연복합추출물 함유 세럼의 제조Example 7: Preparation of Serum Containing Natural Complex Extract
상기 실시예 6에서 제조된 복합추출물을 함유하는 세럼을 하기 표 9의 조성에 따라 통상의 방법으로 제조하였다.Serum containing the composite extract prepared in Example 6 was prepared in a conventional manner according to the composition of Table 9 below.
Claims (8)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230041851A KR102567305B1 (en) | 2023-03-30 | 2023-03-30 | Cosmetic composition for pore shrinking and sebum control containing natural ingredients |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020230041851A KR102567305B1 (en) | 2023-03-30 | 2023-03-30 | Cosmetic composition for pore shrinking and sebum control containing natural ingredients |
Publications (1)
Publication Number | Publication Date |
---|---|
KR102567305B1 true KR102567305B1 (en) | 2023-08-17 |
Family
ID=87800067
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020230041851A KR102567305B1 (en) | 2023-03-30 | 2023-03-30 | Cosmetic composition for pore shrinking and sebum control containing natural ingredients |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR102567305B1 (en) |
Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101194767B1 (en) | 2012-04-04 | 2012-10-25 | 고려대학교 산학협력단 | Cosmetic compound containing green apple for pore-minimizing and inhibiting secretion of sebum |
KR20160007534A (en) * | 2013-05-16 | 2016-01-20 | 디에스엠 아이피 어셋츠 비.브이. | Cosmetic composition comprising a sebum control agent, a skin exfoliation agent and/or a collagen enhancing agent, the composition also comprising porous cross-linked polymethylmethacrylate bead particles |
KR101628939B1 (en) | 2015-12-14 | 2016-06-09 | 백진주 | Cosmetic composition for improving atopic dermatitis and dry skin containing the botanical extracts prepared by bioconversion |
KR102019632B1 (en) * | 2019-03-06 | 2019-09-06 | 휘조우 맨내이 바이오로지컬 테크놀로지 컴퍼니 리미티드 | Cosmetic composition for anti-aging containing extract of unripe fruits |
KR102272111B1 (en) * | 2020-02-27 | 2021-07-02 | 주식회사 아단소니아 | Emulsion composition comprising coffee extract with high concentration as an active ingredient and a method of preparing the same |
-
2023
- 2023-03-30 KR KR1020230041851A patent/KR102567305B1/en active IP Right Grant
Patent Citations (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101194767B1 (en) | 2012-04-04 | 2012-10-25 | 고려대학교 산학협력단 | Cosmetic compound containing green apple for pore-minimizing and inhibiting secretion of sebum |
KR20160007534A (en) * | 2013-05-16 | 2016-01-20 | 디에스엠 아이피 어셋츠 비.브이. | Cosmetic composition comprising a sebum control agent, a skin exfoliation agent and/or a collagen enhancing agent, the composition also comprising porous cross-linked polymethylmethacrylate bead particles |
KR101628939B1 (en) | 2015-12-14 | 2016-06-09 | 백진주 | Cosmetic composition for improving atopic dermatitis and dry skin containing the botanical extracts prepared by bioconversion |
KR102019632B1 (en) * | 2019-03-06 | 2019-09-06 | 휘조우 맨내이 바이오로지컬 테크놀로지 컴퍼니 리미티드 | Cosmetic composition for anti-aging containing extract of unripe fruits |
KR102272111B1 (en) * | 2020-02-27 | 2021-07-02 | 주식회사 아단소니아 | Emulsion composition comprising coffee extract with high concentration as an active ingredient and a method of preparing the same |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
KR101315265B1 (en) | Cosmetic composition for improving skin senescence | |
KR101915952B1 (en) | Composition for anti-oxidant, anti-inflammatory and skin regeneration comprising Houttuynia cordata thumb extract as effective component | |
KR101017709B1 (en) | Cosmetic composition comprising the herbal mixed extract comprising panax ginseng c.a meyer showing hair-growth stimulating activity and preventing activity from hair loss | |
KR101868507B1 (en) | Cosmetic Composition for Anti-oxidation, Anti-inflammatory and Anti-wrinkling Comprising Enzyme-treated Extracts of Annona Muricata and Method for Manufacturing the Same | |
KR102130571B1 (en) | Low irritating cosmetic composition for skin whitening comprising albutin and extract of Euterpe oleracea fruit | |
KR102617856B1 (en) | A composition for anti-aging comprising mixture of snow lotus (Saussurea Involucrata), Usnea Barbata (Lichen) and Panax Ginseng Root extracts/ Bacillus ferment | |
KR102300581B1 (en) | Compositions for improving skin conditions comprising plant extracts or fractions thereof | |
KR101350292B1 (en) | Cosmetic composition containing fermented extracts of panax ginseng root, ganoderma lucidum and white tea and method for preparing the same | |
KR20200134929A (en) | Cosmetic composition containing complex medicinal herbs extract for skin whitening and anti-wrinkle effect and manufacturing method thereof | |
KR102122960B1 (en) | Black Platycodon Grandiflorum root and Black Angelica Sinensis root, Black Zingiber Officinale (Ginger) Root complex with an anti-inflammatory, anti-allergic and atopic skin improvement, a preparation method thereof and a cosmetic composition of the same | |
KR101921832B1 (en) | Cosmetic Compositions for Skin Whitening Containing Ginseng Steaming Extract | |
KR101489935B1 (en) | Method for preparing mugwort extract and cosmetic composition comprising mugwort extract prepared therefrom | |
KR101793098B1 (en) | Natural plant mixed extracts that regulate heat of the skin and a cosmetic composition for skin heat anti-aging that containing the same | |
KR102567305B1 (en) | Cosmetic composition for pore shrinking and sebum control containing natural ingredients | |
KR100985228B1 (en) | Cosmetic composition using wax gourd for improving skin | |
KR20180087592A (en) | Cometic composition for skin whitening, anti-wrinkle and skin regeneration comprising nine times-steaming ginseng extract and water-soluble pearl as active ingredient | |
KR102025859B1 (en) | Cosmetic or phamaceutical composition comprising herb extract and method for preparing the same | |
KR102056263B1 (en) | A cosmetic composition comprising extract of coffee silver skin and coffee grounds | |
KR20190102364A (en) | Anti-aging composition and cosmetic using the same | |
JP2010222273A (en) | Hair-growing agent composition | |
KR101856374B1 (en) | Cosmetic composition comprising steamed root extract of Acanthopanax senticosus for protecting photo-damaged skin | |
KR20190025863A (en) | Cosmetic or phamaceutical composition comprising herb extract and method for preparing the same | |
KR102709528B1 (en) | A composition for preventing or treating vaginitis and vaginitis dryness containing lactobacillus and natural extracts | |
KR102692062B1 (en) | A cosmetic composition having anti-oxidant, anti-inflammatory, protection of skin cell induced by ultraviolet ray and skin whitening effects comrising camellia sinensis extract, rumex crispus extract and inula britannica extract | |
KR20140086214A (en) | The method for manufacturing panax ginseng composite by using the punica granatum concentrate for skin whitening, and the panax ginseng composite made by the method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant |